Chemours backs longer refrigerant transition: what it means for Chemours stock
Published on 10/05/2026 at 06:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSChemours (ISIN US1638511089) supports a 13-year transition timeline for automotive refrigerants under proposed European Union PFAS rules, according to Finanznachrichten on September 28, 2026. The company argues that new refrigerant technologies require development, validation and manufacturing time before broad deployment.
Regulation supports Opteon demand
The proposed transition matters because Chemours sells Opteon refrigerants through its Thermal and Specialized Solutions segment. The company said the previous move from R-134a to R-1234yf took more than 15 years, making a minimum 13-year timeline relevant to product planning and customer adoption.
The regulatory argument also creates a counterweight to near-term demand pressure. Alternative solutions such as propane and carbon dioxide require different vehicle architectures, safety controls or higher-pressure components, which can increase design complexity and costs, according to the September 28 release linked above.
Second-quarter cash flow improves
Chemours reported USD 1.59 billion in net sales for the second quarter of 2026, down from USD 1.62 billion in the second quarter of 2025. GAAP net loss narrowed to USD 274.0 million from USD 380.0 million, while adjusted EBITDA declined to USD 247.0 million from USD 260.0 million.
Cash generation provided the clearest improvement. Free cash flow reached USD 114.0 million in the second quarter of 2026, up from USD 50.0 million a year earlier, an increase of 128.00 percent. Operating cash flow was USD 158.0 million, compared with USD 93.0 million in the second quarter of 2025, while net leverage stood at 4.4 times as of June 30, 2026.
Market value and yearly range
The last Lang & Schwarz prior close was EUR 12.18 on October 2, 2026. Chemours had a market capitalization of USD 2.1 billion as of October 2, 2026, and its 52-week range was USD 9.13 to USD 28.67 on that date. The contrast between improving free cash flow and leverage above the company target of below 3.0 times leaves balance-sheet execution as a central valuation factor.
Chemours stock facts
- Company: The Chemours Company
- ISIN: US1638511089
- Ticker: CC
- Primary exchange: New York Stock Exchange
- Prior close Lang & Schwarz (October 2, 2026): EUR 12.18
- Market capitalization: USD 2.1 billion (as of October 2, 2026)
- 52-week range: USD 9.13-USD 28.67 (as of October 2, 2026)
- Sector / Industry: Basic Materials / Chemicals - Specialty
- Index membership: S&P SmallCap 600
